Austin G Kulasekararaj Selected Research

MicroRNAs (MicroRNA)

7/2016

RPL27A is a target of miR-595 and may contribute to the myelodysplastic phenotype through ribosomal dysgenesis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Austin G Kulasekararaj Research Topics

Disease

25	Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria) 03/2024 - 01/2015
15	Hemolysis 02/2024 - 11/2018
11	Aplastic Anemia (Anemia, Hypoplastic) 04/2024 - 01/2013
8	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 10/2023 - 10/2012
6	COVID-19 12/2023 - 01/2020
5	Fatigue 03/2024 - 01/2019
5	Infections 05/2023 - 09/2015
4	Anemia 03/2024 - 01/2015
3	Bone Marrow Failure Disorders 05/2023 - 05/2015
3	Neoplasms (Cancer) 01/2022 - 10/2014
3	Chronic Disease (Chronic Diseases) 11/2021 - 01/2019
2	VEXAS syndrome 02/2024 - 12/2023
2	Thrombocytopenia (Thrombopenia) 12/2023 - 10/2023
2	Thrombosis (Thrombus) 07/2022 - 01/2020
2	idiopathic Aplastic anemia 01/2022 - 10/2014
2	Bronchiolitis Obliterans Syndrome 10/2014 - 11/2013
2	Cytopenia 11/2013 - 01/2013
1	Graft vs Host Disease (Graft-Versus-Host Disease) 04/2024
1	Hemolytic Anemia 03/2024
1	Asthenia 12/2023
1	Cholecystitis 12/2023
1	Abdominal Pain (Pain, Abdominal) 12/2023
1	Rare Diseases (Rare Disease) 12/2023
1	Skin Manifestations 12/2023
1	Leukopenia 12/2023
1	Neutropenia 12/2023
1	Paramyxoviridae Infections (Parainfluenza) 05/2023
1	Human Influenza (Influenza) 05/2023
1	Virus Diseases (Viral Diseases) 05/2023
1	Hematologic Neoplasms (Hematological Malignancy) 05/2023
1	Autoimmune Hemolytic Anemia (Cold Agglutinin Disease) 01/2021
1	Hemolytic-Uremic Syndrome 01/2021
1	Bone Marrow Diseases (Bone Marrow Disease) 11/2020
1	Inflammation (Inflammations) 01/2020
1	Headache (Headaches) 01/2019
1	monosomy Chromosome 7 07/2016
1	Disease Progression 05/2015
1	Thalassemia 01/2015
1	Sickle Cell Anemia (Hemoglobin S Disease) 01/2015
1	HIV Infections (HIV Infection) 11/2014
1	Autosomal Dominant Dyskeratosis Congenita 09/2013
1	Pancytopenia 09/2013
1	Dyskeratosis Congenita (X-Linked Dyskeratosis Congenita) 09/2013
1	Retinal Neovascularization 09/2013
1	Vitreous Hemorrhage 09/2013

Drug/Important Bio-Agent (IBA)

16	eculizumab FDA Link 02/2024 - 11/2018
11	Complement System Proteins (Complement)IBA 12/2023 - 11/2018
10	ravulizumabIBA 03/2024 - 11/2018
7	Complement Inactivating AgentsIBA 03/2024 - 01/2019
4	Hemoglobins (Hemoglobin)IBA 03/2024 - 01/2019
3	Monoclonal AntibodiesIBA 12/2023 - 11/2018
3	danicopanIBA 12/2023 - 11/2021
3	eltrombopag FDA Link 10/2023 - 11/2014
3	Complement C5 (Complement 5)IBA 01/2023 - 07/2022
3	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 11/2013 - 01/2013
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 12/2023 - 12/2021
2	Alanine Transaminase (SGPT)IBA 12/2023 - 12/2021
2	Complement Factor D (Factor D)IBA 12/2023 - 12/2021
2	TESIBA 01/2022 - 11/2020
2	Azacitidine (5 Azacytidine)FDA Link 01/2017 - 08/2013
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 11/2013 - 01/2013
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 04/2024
1	BilirubinIBA 03/2024
1	pegcetacoplanIBA 02/2024
1	EnzymesIBA 12/2023
1	zilucoplanIBA 08/2023
1	AndrogensIBA 05/2023
1	Biomarkers (Surrogate Marker)IBA 01/2023
1	Proteins (Proteins, Gene)FDA Link 01/2023
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 09/2022
1	Complement Membrane Attack Complex (Membrane Attack Complex)IBA 11/2021
1	COVID-19 VaccinesIBA 01/2021
1	romiplostim FDA Link 01/2021
1	SteroidsIBA 01/2021
1	Rituximab (Mabthera)FDA Link 01/2021
1	VaccinesIBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2020
1	MicroRNAs (MicroRNA)IBA 07/2016
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 09/2015
1	Lenalidomide (CC 5013)FDA Link 05/2015
1	Protons (Proton)IBA 01/2015
1	IronIBA 01/2015
1	Thrombopoietin ReceptorsIBA 11/2014
1	Immunosuppressive Agents (Immunosuppressants)IBA 11/2014
1	Alemtuzumab (Campath)FDA Link 11/2013
1	Retinaldehyde (Retinal)IBA 09/2013
1	Fluorescein (Funduscein)FDA LinkGeneric 09/2013

Therapy/Procedure

12	Therapeutics 03/2024 - 10/2014
5	Transplantation 04/2024 - 10/2014
3	Hematopoietic Stem Cell Transplantation 01/2022 - 04/2013
2	Stem Cell Transplantation 11/2014 - 11/2013
1	Cell Transplantation 02/2024
1	Treatment Delay 01/2023
1	Drug Therapy (Chemotherapy) 01/2022
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2022
1	Immunotherapy 01/2022
1	Blood Transfusion (Blood Transfusions) 11/2021
1	Erythrocyte Transfusion 07/2021
1	Critical Care (Surgical Intensive Care) 01/2021
1	Intravenous Infusions 01/2020